Brazilian Health Regulator Anvisa Authorizes Trials for GSK-Medicago COVID Vaccine Brazilian Health Regulator Anvisa Authorizes Trials for GSK-Medicago COVID Vaccine
Brazilian health regulator Anvisa approved on Thursday the beginning of clinical trials in the country for a new COVID vaccine developed by Canada ' s Medicago and GlaxoSmithKline, Anvisa said in a statement.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: Brazil Health | Canada Health | Clinical Trials | Health | Infectious Diseases | Vaccines